Method for treating or preventing idiopathic polypoidal choroidal vasculopathy (IPCV)
US11596667B2 · kind B2 · utility
2Cited by
0References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 16, 2018 |
| Grant date | Mar 7, 2023 |
| Priority date | — |
| Expiry date | Nov 16, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating or preventing idiopathic polypoidal choroidal vasculopathy is provided comprising intravitreal injections of Zimura™ (or another anti-C5 agent) and Eylea® (or another VEGF antagonist).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.